
Russell Mars Howerton MD
Surgical Oncology (Other than Breast)
Professor of Surgery, Wake Forest University
Join to View Full Profile
S Hawthorne RdWinston Salem, NC 27157
Phone+1 336-716-2255
Fax+1 336-716-6637
Dr. Howerton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Russell Howerton is a general surgeon based in Winston Salem, NC, specializing in surgical oncology with a focus on non-breast cancers. He completed his surgical residency at Tufts Medical Center and holds a medical degree from Vanderbilt University School of Medicine. Dr. Howerton serves as the Chief Medical Officer at Wake Forest Baptist Health and has held an academic position as Associate Professor at Wake Forest School of Medicine since 1992. He is experienced in minimally invasive and hepatopancreatobiliary surgeries. His research includes various publications on pancreatic and liver surgeries, and he has been recognized with honors such as America's Top Doctors and Best Doctors in America.
Education & Training
- Tufts Medical CenterResidency, Surgery, 1984 - 1989
- Vanderbilt University Medical CenterInternship, Transitional Year, 1983 - 1984
- Vanderbilt University School of MedicineClass of 1983
- Johns Hopkins UniversityB.A., With Honors, 1979
Certifications & Licensure
- NC State Medical License 1992 - 2025
- FL State Medical License 2015 - 2017
- OH State Medical License 1990 - 1992
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
- Best Doctors in America 2009
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsComparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resectable pancreatic cancer patients.Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky, Richard A Erali, Timothy Pardee
Journal of Surgical Oncology. 2023-10-01 - 1 citationsRisk factors and outcomes for cholangitis after hepatic resection.Christopher W Mangieri, Matthew A Strode, Omeed Moaven, Cristian D Valenzuela, Richard A Erali
Langenbeck's Archives of Surgery. 2023-06-17 - 1 citationsEffect of preoperative liver-directed therapy prior to hepatic resection.Christopher W Mangieri, Cristian D Valenzuela, Matthew A Strode, Richard A Erali, Perry Shen
American Journal of Surgery. 2023-04-01
Journal Articles
- Optimal Timing of Systemic Therapy in Resectable Colorectal Liver MetastasesIhemelandu C, Levine EA, Aklilu M, Yacoub G, Howerton RM, Bolemon B, Graham M, Russell G, Shen P, American Surgeon, 1/1/2013
- Oncocytic Biliary Cystadenocarcinoma: A Case Report and Review of the LiteratureBardin R, Trupiano J, Howerton R, Geisinger K, Archives of Pathology & Laboratory Medicine, 11/1/2011
- Peritoneal Surface Disease from Colorectal Cancer: Comparison with the Hepatic Metastases Surgical Paradigm in Optimally Resected PatientsShen P, Kurt T, Stewart JH, Howerton RM, Loggie BW, Russell GB, Levine EA, Annals of Surgical Oncology, 1/1/2008
- Join now to see all
Press Mentions
- Pandemic Staffing Strategies Receive Accolades from Hospital EmployeesOctober 15th, 2021
- Nationally-Recognized 'Best Hospital' Snags Award for Exceptional PAsDecember 19th, 2018
- Errant Cancer Diagnosis, Unneeded Surgery Leave North Wilkesboro Woman with Pain, NumbnessMay 21st, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: